KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Short-term Investments (2016 - 2017)

Zimmer Biomet Holdings (ZBH) has 9 years of Short-term Investments data on record, last reported at $27.9 million in Q1 2017.

  • For Q1 2017, Short-term Investments rose 108.21% year-over-year to $27.9 million; the TTM value through Mar 2017 reached $27.9 million, up 108.21%, while the annual FY2015 figure was $164.6 million, 73.13% down from the prior year.
  • Short-term Investments reached $27.9 million in Q1 2017 per ZBH's latest filing, up from $13.4 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $779.8 million in Q3 2014 and bottomed at $13.4 million in Q1 2016.
  • Average Short-term Investments over 5 years is $448.2 million, with a median of $525.9 million recorded in 2013.
  • Peak YoY movement for Short-term Investments: crashed 97.26% in 2016, then soared 108.21% in 2017.
  • A 5-year view of Short-term Investments shows it stood at $727.0 million in 2013, then dropped by 15.75% to $612.5 million in 2014, then tumbled by 73.13% to $164.6 million in 2015, then crashed by 91.86% to $13.4 million in 2016, then soared by 108.21% to $27.9 million in 2017.
  • Per Business Quant database, its latest 3 readings for Short-term Investments were $27.9 million in Q1 2017, $13.4 million in Q3 2016, and $13.4 million in Q1 2016.